PCK2 and Insulin resistance: It leads to the inhibition of gluconeogenesis and glycolysis through reduced expression of PEPCK phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6 phosphatase (G6Pase), with a potential protective role in insulin resistance and type II diabetes (Figure 2).